Literature DB >> 9489765

Tissue engineered skeletal muscle: preparation of highly dense, highly oriented hybrid muscular tissues.

T Okano1, T Matsuda.   

Abstract

We prepared highly dense, highly oriented hybrid muscular tissues that are composed of C2C12 cells (skeletal muscle myoblast cell line) and type I collagen. A cold mixture of C2C12 cells suspended in DMEM and type I collagen solution was poured into capillary tube molds of two different sizes (inner diameters; 0.90 and 0.53 mm, respectively). One end of each mold was sealed. Upon centrifugation (1000 rpm, 5 min) and subsequent thermal gelation, a rod-shaped gel was obtained. It was cultured in an agarose gel-coated dish for 7 days (first for 3 days in a growth medium and then for 4 days in a differentiation medium), during which time it shrank to become a highly dense tissue. Small-diameter rod-shaped, highly dense cellular assemblages with multinucleated myotubes were formed and only few necrotic cells at the core of the tissue were observed. On the other hand, a ring-shaped tissue prepared using a specially devised agarose gel mold was subjected to cyclic stretching at 60 rpm, resulting in the formation of a highly dense, highly oriented hybrid muscular tissue in which both densely accumulated cells and collagen fiber bundles tended to be aligned in the direction of stretching. The hybrid muscular tissues that were prepared using via sequential procedures of a centrifugal cell packing method and a mechanical stress-loading method became closer to native muscular tissues in terms of cell density and orientation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489765     DOI: 10.1177/096368979800700110

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.139


  25 in total

Review 1.  Closer to nature: new biomaterials and tissue engineering in ophthalmology.

Authors:  B Allan
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

2.  Tissue engineering for skeletal muscle regeneration.

Authors:  Roberto Rizzi; Claudia Bearzi; Arianna Mauretti; Sergio Bernardini; Stefano Cannata; Cesare Gargioli
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

3.  A novel in vitro three-dimensional skeletal muscle model.

Authors:  Michele L Marquette; Diane Byerly; Marguerite Sognier
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-05       Impact factor: 2.416

4.  Voluntary movement controlled by the surface EMG signal for tissue-engineered skeletal muscle on a gripping tool.

Authors:  Ken-ichiro Kabumoto; Takayuki Hoshino; Yoshitake Akiyama; Keisuke Morishima
Journal:  Tissue Eng Part A       Date:  2013-06-11       Impact factor: 3.845

Review 5.  Striated muscle function, regeneration, and repair.

Authors:  I Y Shadrin; A Khodabukus; N Bursac
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

Review 6.  In vitro models of neuromuscular junctions and their potential for novel drug discovery and development.

Authors:  Olaia F Vila; Yihuai Qu; Gordana Vunjak-Novakovic
Journal:  Expert Opin Drug Discov       Date:  2019-12-17       Impact factor: 6.098

Review 7.  Engineered skeletal muscles for disease modeling and drug discovery.

Authors:  Jason Wang; Alastair Khodabukus; Lingjun Rao; Keith Vandusen; Nadia Abutaleb; Nenad Bursac
Journal:  Biomaterials       Date:  2019-08-08       Impact factor: 12.479

8.  Bioengineered three-dimensional physiological model of colonic longitudinal smooth muscle in vitro.

Authors:  Shreya Raghavan; Mai T Lam; Lesley L Foster; Robert R Gilmont; Sita Somara; Shuichi Takayama; Khalil N Bitar
Journal:  Tissue Eng Part C Methods       Date:  2010-10       Impact factor: 3.056

Review 9.  Tissue engineering of functional skeletal muscle: challenges and recent advances.

Authors:  Weining Bian; Nenad Bursac
Journal:  IEEE Eng Med Biol Mag       Date:  2008 Sep-Oct

10.  Use of a novel collagen matrix with oriented pore structure for muscle cell differentiation in cell culture and in grafts.

Authors:  V Kroehne; I Heschel; F Schügner; D Lasrich; J W Bartsch; H Jockusch
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.